Literature DB >> 11506728

Expression of liver-specific functions by rat hepatocytes seeded in treated poly(lactic-co-glycolic) acid biodegradable foams.

V Hasirci1, F Berthiaume, S P Bondre, J D Gresser, D J Trantolo, M Toner, D L Wise.   

Abstract

Techniques of liver replacement would benefit patients awaiting donor livers and may be a substitute for transplantation in patients whose livers can regenerate. Poly(lactic-co-glycolic acid) (PLGA) copolymers are biodegradable and have been shown to be useful as scaffolds for seeding and culturing various types of cells. In this study, foam disks were prepared from PLGA (lactic-to-glycolic mole ratio of 85:15) by lyophilization of benzene (5% w/v) solutions. These disks were then used as scaffolds for rat hepatocyte culture. Foams were coated with either a type I collagen gel (0.1% w/v), coated with gelatin (5% w/v), or treated with oxygen plasma (25 W, 90 s) to modify their surface chemistry and wettability. The disks were then seeded with rat hepatocytes (10(6)/mL) and cultured for a period of 2 weeks. All surface treatments resulted in increased hydrophilicity, the greatest being obtained by collagen treatment (contact angle < 10 degrees ), and a minimal decrease in void fraction (5%). DNA content after a 2-week culture period increased proportionally with the wettability of the treated foam surface. Urea synthesis in untreated foams averaged 15.3 +/- 2.3 microg/h/microg DNA, which was significantly higher than that for controls, whereas gelatin and collagen treated foams exhibited urea synthetic rates below the control levels at all times. The DNA content decreased significantly by about 50% between days 1 and 12. PLGA foams, treated and untreated, represent a promising scaffold for scaling up hepatocyte cultures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506728     DOI: 10.1089/10763270152436445

Source DB:  PubMed          Journal:  Tissue Eng        ISSN: 1076-3279


  14 in total

Review 1.  Emerging In Vitro Liver Technologies for Drug Metabolism and Inter-Organ Interactions.

Authors:  Shyam Sundhar Bale; Laura Moore; Martin Yarmush; Rohit Jindal
Journal:  Tissue Eng Part B Rev       Date:  2016-06-01       Impact factor: 6.389

2.  Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration.

Authors:  Fengfu Li; Bernard Hurley; Yun Liu; Brian Leonard; May Griffith
Journal:  Open Ophthalmol J       Date:  2012-06-25

Review 3.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

Review 4.  Models and methods for in vitro testing of hepatic gap junctional communication.

Authors:  Michaël Maes; Sara Crespo Yanguas; Joost Willebrords; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2015-09-28       Impact factor: 3.500

5.  Delivery systems for in vivo use of nucleic Acid drugs.

Authors:  R R Resende; H A M Torres; K K Yuahasi; Majumder P; Ulrich H
Journal:  Drug Target Insights       Date:  2007-08-09

6.  Physical and degradation properties of PLGA scaffolds fabricated by salt fusion technique.

Authors:  Naveen Kumar Mekala; Rama Raju Baadhe; Sreenivasa Rao Parcha; Prameela Devi Yalavarthy
Journal:  J Biomed Res       Date:  2013-06-25

7.  Degradable hydrogels derived from PEG-diacrylamide for hepatic tissue engineering.

Authors:  Kelly R Stevens; Jordan S Miller; Brandon L Blakely; Christopher S Chen; Sangeeta N Bhatia
Journal:  J Biomed Mater Res A       Date:  2015-04-30       Impact factor: 4.396

Review 8.  Application of Advanced Nanomaterials for Kidney Failure Treatment and Regeneration.

Authors:  Aziz Eftekhari; Solmaz Maleki Dizaj; Elham Ahmadian; Agata Przekora; Seyed Mahdi Hosseiniyan Khatibi; Mohammadreza Ardalan; Sepideh Zununi Vahed; Mahbuba Valiyeva; Sevil Mehraliyeva; Rovshan Khalilov; Mohammad Hasanzadeh
Journal:  Materials (Basel)       Date:  2021-05-29       Impact factor: 3.623

Review 9.  Microporous membrane-based liver tissue engineering for the reconstruction of three-dimensional functional liver tissues in vitro.

Authors:  Junichi Kasuya; Kazuo Tanishita
Journal:  Biomatter       Date:  2012 Oct-Dec

Review 10.  Cell patterning for liver tissue engineering via dielectrophoretic mechanisms.

Authors:  Wan Nurlina Wan Yahya; Nahrizul Adib Kadri; Fatimah Ibrahim
Journal:  Sensors (Basel)       Date:  2014-07-02       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.